| Literature DB >> 24803570 |
Jeanette Teo1, Sean Yang-Yi Tan2, Yang Liu3, Martin Tay2, Yichen Ding3, Yingying Li4, Staffan Kjelleberg5, Michael Givskov6, Raymond T P Lin1, Liang Yang7.
Abstract
Acquisition of Elizabethkingia infections in intensive care units (ICUs) has risen in the past decade. Treatment of Elizabethkingia infections is challenging due to the lack of effective therapeutic regimens, leading to a high mortality rate. Elizabethkingia infections have long been attributed to Elizabethkingia meningoseptica. Recently, we used whole-genome sequencing to reveal that E. anophelis is the pathogenic agent for an Elizabethkingia outbreak at two ICUs. We performed comparative genomic analysis of seven hospital-isolated E. anophelis strains with five available Elizabethkingia spp. genomes deposited in the National Center for Biotechnology Information Database. A pan-genomic approach was applied to identify the core- and pan-genome for the Elizabethkingia genus. We showed that unlike the hospital-isolated pathogen E. meningoseptica ATCC 12535 strain, the hospital-isolated E. anophelis strains have genome content and organization similar to the E. anophelis Ag1 and R26 strains isolated from the midgut microbiota of the malaria mosquito vector Anopheles gambiae. Both the core- and accessory genomes of Elizabethkingia spp. possess genes conferring antibiotic resistance and virulence. Our study highlights that E. anophelis is an emerging bacterial pathogen for hospital environments.Entities:
Keywords: Elizabethkingia; comparative genomics; pan/core-genomes
Mesh:
Year: 2014 PMID: 24803570 PMCID: PMC4041001 DOI: 10.1093/gbe/evu094
Source DB: PubMed Journal: Genome Biol Evol ISSN: 1759-6653 Impact factor: 3.416
FA phylogenetic tree showing the 12 Elizabethkingia spp. This phylogenetic tree was produced by pair-wise genome comparisons by Progressive Mauve.
FSNP distance matrix among the 12 Elizabethkingia spp. SNP difference between each pair of Elizabethkingia spp. was calculated by using the snpTree web server.
FSequence comparison by alignment. The Elizabethkingia anophelis NUHP1 strain (red arc) was aligned against: E. anophelis R26 strain (blue arc), E. anophelis Ag1 (orange arc), E. meningoseptica ATCC 12535 (NITE) (yellow arc), and E. meningoseptica 502 (light green arc). Colored links between contigs represent homologous regions spanning: 102–103 bp (green), 103–104 bp (blue), and above 104 bp (red). The presence of red links between the NUHP1 strain and E. anophelis R26, Ag1 contigs, and E. meningoseptica 502 contigs indicate a high degree of similarity between these genomes.
FCurves for the core-genomes, pan-genomes, and numbers of new genes of the 12 Elizabethkingia spp.
Proteins Involved in Antibiotic Resistance Encoded from Core- and Accessory Genomes of the Elizabethkingia spp. Identified by BLAST Search against the Comprehensive Antibiotic Resistance Database
| Database ID | % Identity | Antibiotic Resistance | Annotation |
|---|---|---|---|
| Core genome | |||
| (AGly)ApmA:FN806789:2858–3682:822 | 44.71 | Aminoglycosides | Aminocyclitol acetyltransferase. Confers apramycin resistance. |
| (Bla)AIM-1:AM998375:1173–2084:912 | 30.88 | Beta-lactamases | Metallo-beta-lactamase AIM-1. Imipenemase. |
| (Bla)B-1:AF189298:1–750:750 | 94.35 | Beta-lactamases | |
| (Bla)Beta-lactamase_class-A:NC_010410:1803480–1804499:1020 | 35.09 | Beta-lactamases | Beta-lactamase_class-A |
| (Bla)SFO-1:FJ848785:4719–5594:876 | 32.5 | Beta-lactamases | AmpR of SFO-1; activator of ampA. |
| (Flq)OqxA:EU370913:46652–47827:1176 | 30.71 | Fluoroquinolones | OqxA membrane-fusion protein. component of RND-type multidrug efflux pump that confers resistance to olaquindox |
| (Flq)OqxBgb:EU370913:47851–51003:3153 | 39.96 | Fluoroquinolones | OqxB integral membrane protein. component of RND-type multidrug efflux pump that confers resistance to olaquindox |
| (Gly)VanH:DQ246438:124–1179:1056 | 33.65 | Glycopeptides | VanH, D-lactate dehydrogenase. |
| (Gly)VanR-A:M97297:3976–4671:696 | 32.33 | Glycopeptides | VanR. |
| (Gly)VanR-B:AY655721:69–728:660 | 34.15 | Glycopeptides | VanRB, regulator protein. |
| (Gly)VanT:AF162694:3008–5104:2097 | 32.25 | Glycopeptides | Serine racemase VanT. converts L-serine to D-serine; involved in vancomycin resistance |
| (Gly)VanW-B:AY655721:3069–3896:828 | 33.57 | Glycopeptides | VanW. |
| (MLS)CarA:M80346:411–2066:1656 | 41.54 | Macrolide-lincosamide-streptogramin | CarA, carbomycin resistance protein. |
| (MLS)CfrA:AM408573:10028–11077:1050 | 31.9 | Macrolide-lincosamide-streptogramin | Cfr, rRNA methylase, mediates the PhLOPSA resistance phenotype |
| (Tet)otrA:X53401:349–2341:1992 | 43.66 | Tetracyclines | OtrA, oxytetracycline resistance |
| (Tmt)Dfr16:AF077008:115–558:474 | 34.03 | Trimethoprim | DHFRXVI, trimethoprim resistant dihydrofolate reductase |
| Accessory genome | |||
| (AGly)Aac3-Ig:CP000282:2333620–2334096:477 | 33.56 | Aminoglycosides | Sde_1840,Gentamicin 3'-N-acetyltransferase |
| (AGly)Aac6:DQ302723:81–482:402 | 31.09 | Aminoglycosides | Aac(6'), aminoglycoside-6'-N-acetyltransferase |
| (Bla)ACC-3:AF180957:1–1131:1131 | 30.56 | Beta-lactamases | ACC-3, AMPC cephalosporinase precursor protein ACC-3 |
| (Bla)IND-7:AB529520:1–720:720 | 72.73 | Beta-lactamases | BlaIND-7, metallo-beta-lactamase IND-7 |
| (Bla)OCH-7:AJ295345:1–1173:1173 | 30.15 | Beta-lactamases | Bla OCH-7, beta-lactams hydrolysis |
| (Flq)OqxBgb:EU370913:47851–51003:3153 | 31.64 | Fluoroquinolones | pOLA52_67, OqxB integral membrane protein, component of RND-type multidrug efflux pump that confers resistance to olaquindox |
| (Gly)VanRc3:AY033764:3846–4541:696 | 30.34 | Glycopeptides | VanRc3 |
| (Gly)VanR-M:FJ349556:982–1680:699 | 32.35 | Glycopeptides | Van operon, response regulator |
| (MLS)CarA:M80346:411–2066:1656 | 34.88 | Macrolide-lincosamide-streptogramin | Carbomycin resistance protein (carA) |
| (MLS)LmrA:X59926:318–1763:1446 | 30.43 | Macrolide-lincosamide-streptogramin | LmrA gene for lincomycin resistance protein |
| (MLS)MefB:FJ196385:11084–12313:1230 | 36.18 | Macrolide-lincosamide-streptogramin | Macrolide efflux pump. |
| (MLS)MsrE:JF769133:7246–8721:1476 | 36.96 | Macrolide-lincosamide-streptogramin | Macrolide efflux protein. |
| (MLS)OleB:L36601:1421–3130:1710 | 37.04 | Macrolide-lincosamide-streptogramin | ATP-binding protein. oleandomycin resistance and secretion |
| (MLS)TlrC:M57437:277–1923:1647 | 30.77 | Macrolide-lincosamide-streptogramin | Tylosin resistance protein (tlrC) gene |
| (MLS)VatF:AF170730:70–735:666 | 31.21 | Macrolide-lincosamide-streptogramin | Streptogramin A acetyl transferase (sat) gene. Confers resistance to class A streptogramins |
| (MLS)vgaa-LC:DQ823382:1–1569:1569 | 31.11 | Macrolide-lincosamide-streptogramin | Lincosamide-streptogramin A resistance protein (vga(A)LC) gene |
| (Rif)Arr7:FN397623:1189–1641:453 | 41.73 | Rifampicin | ADP-ribosyltransferase. Resistance to rifampin. |
| (Tet)OtrB:AF079900:40–1733:1692 | 30.27 | Tetracyclines | Tetracycline efflux protein (otrB) gene |
| (Tet)TetX:M37699:586–1752:1167 | 59.36 | Tetracyclines | Transposon Tn4351 tetracycline resistance protein (tetX) gene |
FThe identified EM-only and EA-only proteins were assigned to Clusters of Orthologous Groups (COGs). The y axis indicates the percentage of genes in a specific function cluster out of the total numbers of EM-only and EA-only proteins, respectively. *The abundances of specific function clusters were compared statistically as described in Rodriguez-Brito et al. (2006) and Allen et al. (2009) using a subsample size of 500 and 1,000 bootstrap replicates at a statistical confidence of 99%.